In order to investigate whether cancer cells harboring GOF mutant p53 can encapsulate the mutated proteins into EVs and release them using the exosomal machinery, we chose to test several complementary cellular systems that originate from several different types of cancer and that contain a series of different p53 GOF mutations. The gene discussed is TP53; the disease is cancer.